Evaluating Drug‐Target Complexes in Therapeutic Monoclonal Antibodies Using A4F‐MALS: Implications for Drug Development and Clinical Design.
| Publicado en: | Journal of Immunology Research Vol. 2026; pp. 1 - 12 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Wiley-Blackwell
5/29/2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=194164018&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 194164018 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 23148861 GZMW jtl: Journal of Immunology Research issn: 23148861 maglogo: N pubinfo: dt: 5/29/2026 vid: 2026 pid: 480 pub: Wiley-Blackwell place: Malden, Massachusetts artinfo: ui: 194164018 10.1155/jimr/8063033 194164018 ppf: 1 ppct: 11 formats: tig: atl: Evaluating Drug‐Target Complexes in Therapeutic Monoclonal Antibodies Using A4F‐MALS: Implications for Drug Development and Clinical Design. aug: au: Liu, Nina Kotowski, Donald Ong, Eric T. Devalaraja-Narashimha, Kishor B. Rosconi, Michael P. Pyles, Erica A. Gurumallesh Prabu, Poorani affil: Product Biochemistry,, Regeneron Pharmaceuticals, Inc.,, Tarrytown, New York,, USA, regeneron.com sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|